表紙
市場調査レポート - 235295

網膜静脈閉塞:世界の治験レビュー

Retinal Vein Occlusion Global Clinical Trials Review, H1, 2015

発行 GlobalData
出版日 ページ情報 英文 127 Pages
電子版即納可
価格
Back to Top
網膜静脈閉塞:世界の治験レビュー Retinal Vein Occlusion Global Clinical Trials Review, H1, 2015
出版日: 2015年06月11日 ページ情報: 英文 127 Pages
概要

当レポートでは、世界の網膜静脈閉塞治療薬の臨床試験について調査し、地域別の臨床市件数データ、試験段階、試験状況、採用テーマおよびスポンサー企業タイプ別の臨床試験データ、中断(一時中止、廃止、打ち切り)された試験のリストなどを提供しており、概略以下の構成でお届けします。

目次

  • イントロダクション
    • 網膜静脈閉塞
    • レポートガイダンス
  • 臨床試験:地域別
  • 臨床試験:国別
    • 臨床試験に寄与している主要5ヵ国 − アジア太平洋地域
    • 臨床試験に寄与している主要5ヵ国 − 欧州
    • 臨床試験に寄与している主要国 − 北米
    • 臨床試験に寄与している主要国 − 中東およびアフリカ
    • 臨床試験に寄与している主要国 − 中南米
  • 臨床試験 BRIC 諸国
  • 臨床試験 G7 諸国
  • 臨床試験 G7 諸国 , 治験ステータス別
  • 臨床試験 E7 諸国
  • 臨床試験 E7 諸国 , 治験ステータス別
  • 相別臨床試験
    • 進行中の治験:相別
  • 臨床試験:治験ステータス別
  • 未完了の治験
  • 期間ごとの被験者数
  • 有力なスポンサー
    • 主な治験参加企業
  • 有望な治療薬比較
  • 臨床試験プロファイル
    • 臨床試験概要:主要企業
      • Allergan, Inc.
      • Genentech, Inc.
      • Regeneron Pharmaceuticals, Inc.
      • Okuvision GmbH
      • Mid Atlantic Retina
      • Aleris Helse AS
      • Retina Associates of Cleveland, Inc.
      • Alimera Sciences, Inc.
      • Fovea Pharmaceuticals SA
      • 三和化学研究所
      • Bayer AG
      • Novartis AG
      • 参天製薬
      • Eyetech Pharmaceuticals, Inc.
      • F. Hoffmann-La Roche Ltd.
    • 臨床試験概要:トップレベルの大学 / 研究機関 / 病院
      • 京都大学
      • Johns Hopkins University
      • Barnes Retina Institute
      • University of Toronto
      • Shaheed Beheshti Medical University
      • Duke University
      • Medical University of Vienna
      • Yonsei University
      • St. Erik Eye Hospital
      • 滋賀医科大学
      • California Retina Consultants
      • Manhattan Eye Ear & Throat Hospital
      • 山形大学医学部附属病院
      • Retina Macula Institute
      • Instituto Universitario de of talmobiologia Aplicada
      • Midwest Eye-Banks
      • Baqiyatallah Medical Sciences University
      • Stavanger University Hospital
      • Shiraz University of Medical Sciences
      • University of Leipzig
  • 5件の主要臨床プロファイル

付録

図表一覧


このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Retinal Vein Occlusion Global Clinical Trials Review, H1, 2015" provides an overview of Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the clinical trials on Retinal Vein Occlusion. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Retinal Vein Occlusion
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Retinal Vein Occlusion
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Retinal Vein Occlusion Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Retinal Vein Occlusion
      • Apr 23, 2015: ThromboGenics Starts Evaluating JETREA for the Treatment of Retinal Vein Occlusion
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Actavis plc
      • Clinical Trial Overview of Actavis plc
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Regeneron Pharmaceuticals, Inc.
      • Clinical Trial Overview of Regeneron Pharmaceuticals, Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • Valeant Pharmaceuticals International, Inc.
      • Clinical Trial Overview of Valeant Pharmaceuticals International, Inc.
      • S:t Eriks Ogonsjukhus AB
      • Clinical Trial Overview of S:t Eriks Ogonsjukhus AB
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • California Retina Consultants
      • Clinical Trial Overview of California Retina Consultants
      • Asociacion para Evitar la Ceguera en Mexico I.A.P.
      • Clinical Trial Overview of Asociacion para Evitar la Ceguera en Mexico I.A.P.
    • Clinical Trial Overview of Top Institutes / Government
      • Shahid Beheshti University of Medical Sciences
      • Clinical Trial Overview of Shahid Beheshti University of Medical Sciences
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • Shiga University of Medical Science
      • Clinical Trial Overview of Shiga University of Medical Science
      • Barnes Retina Institute
      • Clinical Trial Overview of Barnes Retina Institute
      • Duke University
      • Clinical Trial Overview of Duke University
      • Hallym University Medical Center
      • Clinical Trial Overview of Hallym University Medical Center
      • Manhattan Eye Ear & Throat Hospital
      • Clinical Trial Overview of Manhattan Eye Ear & Throat Hospital
      • Medical University of Vienna
      • Clinical Trial Overview of Medical University of Vienna
      • Mie University
      • Clinical Trial Overview of Mie University
      • Palo Alto Medical Foundation
      • Clinical Trial Overview of Palo Alto Medical Foundation
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Regeneron Pharmaceuticals, Inc., 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Valeant Pharmaceuticals International, Inc., 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by S:t Eriks Ogonsjukhus AB, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by California Retina Consultants, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Asociacion para Evitar la Ceguera en Mexico I.A.P., 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiga University of Medical Science, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Hallym University Medical Center, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Manhattan Eye Ear & Throat Hospital, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Mie University, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials Market, Global, Clinical Trials by Palo Alto Medical Foundation, 2015*

List of Figures

  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Retinal Vein Occlusion to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Retinal Vein Occlusion Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Retinal Vein Occlusion Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top